Skip to main content
. 2018 Jan 4;9(15):12079–12100. doi: 10.18632/oncotarget.23951

Figure 5. Verification of GPNMB, ERAP2, CTSC, and NPC2 in individual FNA cystic fluid samples by Western blot analysis.

Figure 5

(A) Equal amounts of proteins (20 μg) prepared from individual FNA cystic fluid samples were separated by 6-18%-gradient SDS-PAGE, transferred to PVDF membranes, and probed with specific antibodies against the indicated target proteins. SFTPB, which was previously reported as a potential PTC biomarker, was also included in this analysis. (B) The Coomassie-Blue-stained protein profile was used as a loading control.